---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-22-000724"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2022-11-21T23:59:59+00:00"
generated_at: "2026-06-21T15:03:00.584530+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma issues 55.8M Series A Preferred shares to settle $376,711 in convertible debt

## Summary
- Issued 55,809,233 Series A Preferred shares to satisfy $250,000 principal and $126,711 accrued interest on convertible promissory notes.
- Shares issued directly by management under Section 4(a)(2) exemption; no underwriters or commissions paid.
- As of Nov 21, 2022, $510,000 of convertible notes outstanding, including $360,000 convertible at floating rate.

## SEC filing metadata
- accession: 0001607062-22-000724
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2022-11-21T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000724/0001607062-22-000724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000724/rgbp112122form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-22-000724
- JSON: https://secwatch.observer/filing/0001607062-22-000724.json
- Plain text: https://secwatch.observer/filing/0001607062-22-000724.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.